tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Financial Statements

Compare
1 Followers

Oryzon Genomics SA Financial Overview

Oryzon Genomics SA's market cap is currently €223.24M. The company's EPS TTM is €-0.027; its P/E ratio is ―; Oryzon Genomics SA is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is €-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 7.36M€ 14.19M€ 15.70M€ 10.62M€ 9.52M
Gross Profit€ 7.06M€ 13.95M€ 15.23M€ 9.87M€ 8.99M
Operating Income€ -4.42M€ -4.55M€ -5.49M€ -7.01M€ -4.29M
EBITDA€ -4.43M€ -4.26M€ -5.08M€ -6.88M€ -4.16M
Net Income€ -3.67M€ -3.35M€ -4.23M€ -4.69M€ -3.40M
Balance Sheet
Cash & Short-Term Investments€ 5.62M€ 12.26M€ 21.32M€ 28.72M€ 39.60M
Total Assets€ 108.72M€ 106.90M€ 103.70M€ 95.38M€ 94.11M
Total Debt€ 16.21M€ 13.69M€ 17.44M€ 13.77M€ 9.09M
Net Debt€ 10.59M€ 1.43M€ -3.88M€ -14.95M€ -30.51M
Total Liabilities€ 21.67M€ 25.13M€ 31.13M€ 24.12M€ 18.18M
Stockholders' Equity€ 87.04M€ 81.77M€ 72.57M€ 71.26M€ 75.93M
Cash Flow
Free Cash Flow€ -5.69M€ -15.08M€ -16.12M€ -15.39M€ -14.04M
Operating Cash Flow€ -5.69M€ -574.96K€ -1.85M€ -3.63M€ -4.82M
Investing Cash Flow€ -7.81M€ -14.50M€ -14.27M€ -11.72M€ -9.08M
Financing Cash Flow€ 6.87M€ 6.02M€ 8.71M€ 4.12M€ 18.38M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

Oryzon Genomics SA Debt to Assets

Oryzon Genomics SA Cash Flow

Oryzon Genomics SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis